Gerrit Klaerner

Chief Executive Officer & President at Tricida, Inc.

Gerrit Klaerner

Gerrit Klaerner

Chief Executive Officer & President at Tricida, Inc.

Overview
Career Highlights

Relypsa, Inc.
Tricida, Inc.

RelSci Relationships

239

Number of Boards

2

Birthday

1971

Age

49

Contact Data
Trying to get in touch with Gerrit Klaerner? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Gerrit Klaerner likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Symbiomix Therapeutics LLC

Relationship likelihood: Strong

Co-Founder & President at Sibling Capital LLC

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Dean at Yale University - Yale School of Medicine

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Chief Technology Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Chief Development Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Former Partner at Bryan Cave LLP

Relationship likelihood: Strong

Former Chief Scientific Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Paths to Gerrit Klaerner
Potential Connections via
Relationship Science
You
Gerrit Klaerner
Chief Executive Officer & President at Tricida, Inc.
Education

The Max Planck Institute of Molecular Genetics Berlin focuses on research in the fields of molecular genetics.

MS Chemistry

Philipps-University Marburg is a non-profit public higher education university in Germany.

Career History
Chief Executive Officer & President
2013 - Current

Tricida, Inc. is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

Chief Operating Officer
2007 - 2013

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Chief Business Officer
2003 - 2007

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $12.5K
2015

HILLBROOK PROVIDES AN EXTRAORDINARY EDUCATIONAL EXPERIENCE THAT FOSTERS A LOVE OF LEARNING IN OUR STUDENTS AND HELPS THEM DEVELOP THE KNOWLEDGE, SKILLS, AND CONFIDENCE TO ACHIEVE THEIR HIGHEST INDIVIDUAL POTENTIAL IN SCHOOL AND IN LIFE. AT HILLBROOK, STUDENTS ARE KNOWN, RESPECTED, AND VALUED AS INDIVIDUALS AND EVERY DAY IS A JOURNEY OF SELF-DISCOVERY, IMAGINATIVE THINKING, CREATIVE PROBLEM SOLVING, LAUGHTER, AND FRIENDSHIP.

$4,200 - $4,999
2014

HILLBROOK PROVIDES AN EXTRAORDINARY EDUCATIONAL EXPERIENCE THAT FOSTERS A LOVE OF LEARNING IN OUR STUDENTS AND HELPS THEM DEVELOP THE KNOWLEDGE, SKILLS, AND CONFIDENCE TO ACHIEVE THEIR HIGHEST INDIVIDUAL POTENTIAL IN SCHOOL AND IN LIFE. AT HILLBROOK, STUDENTS ARE KNOWN, RESPECTED, AND VALUED AS INDIVIDUALS AND EVERY DAY IS A JOURNEY OF SELF-DISCOVERY, IMAGINATIVE THINKING, CREATIVE PROBLEM SOLVING, LAUGHTER, AND FRIENDSHIP.

Transactions
Details Hidden

Tricida, Inc. raised money in a private placement transaction

Details Hidden

Tricida, Inc. raised money in a private placement transaction

Details Hidden

Tricida, Inc. raised money in a private placement transaction

Investments
Details Hidden

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Details Hidden

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Gerrit Klaerner is affiliated with Tricida, Inc., Relypsa, Inc., Ilypsa, Inc., Symyx Technologies, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerrit Klaerner. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerrit Klaerner's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerrit Klaerner.